Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Metabolite synthesis is another tool within selectAZyme’sTM service offering that provides access to both oxidative and glycosylated products. Almac has implemented state-of-the-art biocatalytic technology for rapid metabolite synthesis, isolation and structural identification.
We have developed both recombinant and microbial P450 technology to access metabolites from mg to 100s grams scale. These enzymes, which mimic human P450 systems, are a powerful tool for accessing difficult to synthesise metabolites rapidly.
- Cloned Human P450
- Cloned Microbial P450
- Extensive microbial collection
Metabolite Isolation/Structure ID
- Analytical and prep LC
- High-field NMR
Almac’s scale-up ability allows us to rapidly take ‘hits’ from conception to gram delivery as and when our customers require the products.
In addition, Almac can also supply radiolabelled metabolites utilising our in-house isotope chemistry group.